Advanced Solid Tumors: STAR0602 Treatment

We are testing a new drug, STAR0602, to see if it can help stimulate the immune system in patients with advanced solid tumors that cannot be surgically removed. This study aims to explore its effects on tumors that have spread locally or to other parts of the body.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonié
Oncologie Médical
Bordeaux, France
Centre Leon Berard
Oncologie Médicale
Meyzieu, France
Institut Curie
Oncologie Médicale
Paris, France

Sponsor: Marengo Therapeutics Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.